Telix Pharmaceuticals TLX
NASDAQ TLX
$9.67 +0.64 (+7.09%)
At close: Nov 4, 2026 · 4:00 PM EST

Telix Pharmaceuticals (TLX) Invested Capital (2023 - 2026)

Updated

Telix Pharmaceuticals (TLX) posted Invested Capital of $1 billion for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Invested Capital (2023 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Telix Pharmaceuticals' Invested Capital came in at $820.4 million, up 10.1% from the prior year.

  • In prior years, Telix Pharmaceuticals' Invested Capital was $744.87 million in the year ended Dec 31, 2024 (+623.8%) and $102.91 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,267.62 Bn 1,241.24 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 666.76 Bn 586.62 Bn 17.30 Bn 126.18 Bn
3 AbbVie 520.19 Bn 488.20 Bn 13.12 Bn 76.32 Bn
4 Merck 370.06 Bn 324.43 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 319.62 Bn 292.86 Bn - -
6 Astrazeneca 293.19 Bn 267.08 Bn 13.26 Bn 39.85 Bn
7 Amgen 257.73 Bn 213.13 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 217.04 Bn 192.15 Bn 6.73 Bn 39.27 Bn
9 Pfizer 174.90 Bn 121.55 Bn 10.94 Bn 148.69 Bn
10 Telix Pharmaceuticals 3.26 Bn 2.22 Bn - 1.00 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Bn
Dec 31, 2025 820.40 Mn
Dec 31, 2024 708.47 Mn
Dec 31, 2023 107.91 Mn
API Access

Telix Pharmaceuticals Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=TLX&period=max&api_key=YOUR_API_KEY